Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Yuki Fujiwara to Macrophages

This is a "connection" page, showing publications Yuki Fujiwara has written about Macrophages.

 
Connection Strength
 
 
 
2.902
 
  1. Fujiwara Y, Komohara Y. Therapeutic Strategies Targeting CD163 and CD169 in Macrophages for Cancer. Pathol Int. 2025 Nov; 75(11):551-561.
    View in: PubMed
    Score: 0.530
  2. Fukuda R, Fujiwara Y, Maruyama T, Komohara Y. CD169-positive macrophages in lymph nodes and the tumor microenvironment: harnessing their biology for clinical diagnosis and anticancer therapeutic strategies. Front Immunol. 2026; 17:1852700.
    View in: PubMed
    Score: 0.138
  3. Yano H, Fujiwara Y, Mito R, Pan C, Ono K, Imamura K, Niidome T, Sawa T, Yamamoto M, Sakagami T, Komohara Y. Mycobacterium avium infection induced PD-L1 overexpression in macrophages: a potential involvement with immune escape. Cell Death Dis. 2026 Jan 09; 17(1):15.
    View in: PubMed
    Score: 0.134
  4. Saito Y, Fujiwara Y, Yamaguchi YL, Tanaka SS, Miura K, Hizukuri Y, Yamashiro K, Hayashi Y, Nakashima Y, Komohara Y. Rodent monocyte-derived macrophages do not express CD163: Comparative analysis using macrophages from living boreoeutherians. Dev Dyn. 2026 04; 255(4):372-402.
    View in: PubMed
    Score: 0.128
  5. Fukuda R, Fujiwara Y, Maeda H, Pan C, Minayoshi Y, Yano H, Mizuta Y, Takano M, Yamada R, Saito Y, Hirata K, Imoto S, Yamasaki K, Oniki K, Saruwatari J, Otagiri M, Watanabe H, Komohara Y, Maruyama T. Lymph node macrophage-targeted interferon alpha boosts anticancer immune responses by regulating CD169-positive phenotype of macrophages. Mol Cancer. 2025 May 03; 24(1):132.
    View in: PubMed
    Score: 0.128
  6. Matsuzaki H, Kai K, Komohara Y, Yano H, Pan C, Fujiwara Y, Yamada R, Iwauchi A, Fukasawa N, Tanaka T, Shimoda M, Watanabe H, Maruyama T, Takeo T, Mikami Y, Mukasa A. Abnormal Vessels Potentially Accelerate Glioblastoma Proliferation by Inducing the Protumor Activation of Macrophages. Cancer Sci. 2025 Apr; 116(4):897-909.
    View in: PubMed
    Score: 0.126
  7. Wada T, Senokuchi T, Shi Y, Furusho T, Morita Y, Sarie M, Hanatani S, Fukuda K, Ishii N, Matsumura T, Fujiwara Y, Komohara Y, Araki E, Kubota N. Orally administrated acetate inhibits atherosclerosis progression through AMPK activation via GPR43 in plaque macrophages. Atherosclerosis. 2025 02; 401:119088.
    View in: PubMed
    Score: 0.124
  8. Kanemitsu K, Yamada R, Pan C, Tsukamoto H, Yano H, Shiota T, Fujiwara Y, Miyamoto Y, Mikami Y, Baba H, Komohara Y. Age-associated reduction of sinus macrophages in human mesenteric lymph nodes. J Clin Exp Hematop. 2024 Jun 27; 64(2):79-85.
    View in: PubMed
    Score: 0.118
  9. Komohara Y, Kurotaki D, Tsukamoto H, Miyasato Y, Yano H, Pan C, Yamamoto Y, Fujiwara Y. Involvement of protumor macrophages in breast cancer progression and characterization of macrophage phenotypes. Cancer Sci. 2023 Jun; 114(6):2220-2229.
    View in: PubMed
    Score: 0.110
  10. Li L, Irie T, Yoshii D, Komohara Y, Fujiwara Y, Esumi S, Kadohisa M, Honda M, Suzu S, Matsuura T, Kohashi K, Oda Y, Hibi T. M-CSFR expression in the embryonal component of hepatoblastoma and cell-to-cell interaction between macrophages and hepatoblastoma. Med Mol Morphol. 2022 Sep; 55(3):236-247.
    View in: PubMed
    Score: 0.104
  11. Yonemitsu K, Miyasato Y, Shiota T, Shinchi Y, Fujiwara Y, Hosaka S, Yamamoto Y, Komohara Y. Soluble Factors Involved in Cancer Cell-Macrophage Interaction Promote Breast Cancer Growth. Anticancer Res. 2021 Sep; 41(9):4249-4258.
    View in: PubMed
    Score: 0.099
  12. Matsusaka K, Fujiwara Y, Pan C, Esumi S, Saito Y, Bi J, Nakamura Y, Mukunoki A, Takeo T, Nakagata N, Yoshii D, Fukuda R, Nagasaki T, Tanaka R, Komori H, Maeda H, Watanabe H, Tamada K, Komohara Y, Maruyama T. a1-Acid Glycoprotein Enhances the Immunosuppressive and Protumor Functions of Tumor-Associated Macrophages. Cancer Res. 2021 09 01; 81(17):4545-4559.
    View in: PubMed
    Score: 0.098
  13. Ishiuchi K, Amber Syed A, Kosuge Y, Fujiwara Y, Makino T, Hirose D. Decaturenol A and known oxalicine related meroterpenoids isolated from Penicillium decaturense RO050, and their new biological activities. Bioorg Med Chem Lett. 2020 08 15; 30(16):127307.
    View in: PubMed
    Score: 0.091
  14. Tanaka R, Saito Y, Fujiwara Y, Jo JI, Tabata Y. Preparation of fibrin hydrogels to promote the recruitment of anti-inflammatory macrophages. Acta Biomater. 2019 04 15; 89:152-165.
    View in: PubMed
    Score: 0.083
  15. Shiraishi D, Fujiwara Y, Horlad H, Saito Y, Iriki T, Tsuboki J, Cheng P, Nakagata N, Mizuta H, Bekki H, Nakashima Y, Oda Y, Takeya M, Komohara Y. CD163 Is Required for Protumoral Activation of Macrophages in Human and Murine Sarcoma. Cancer Res. 2018 06 15; 78(12):3255-3266.
    View in: PubMed
    Score: 0.078
  16. Fujiwara Y, Saito Y, Shiota T, Cheng P, Ikeda T, Ohnishi K, Takeya M, Komohara Y. Natural compounds that regulate lymph node sinus macrophages: Inducing an anti-tumor effect by regulating macrophage activation. J Clin Exp Hematop. 2018; 58(1):17-23.
    View in: PubMed
    Score: 0.077
  17. Iriki T, Ohnishi K, Fujiwara Y, Horlad H, Saito Y, Pan C, Ikeda K, Mori T, Suzuki M, Ichiyasu H, Kohrogi H, Takeya M, Komohara Y. The cell-cell interaction between tumor-associated macrophages and small cell lung cancer cells is involved in tumor progression via STAT3 activation. Lung Cancer. 2017 04; 106:22-32.
    View in: PubMed
    Score: 0.072
  18. Tsuboki J, Fujiwara Y, Horlad H, Shiraishi D, Nohara T, Tayama S, Motohara T, Saito Y, Ikeda T, Takaishi K, Tashiro H, Yonemoto Y, Katabuchi H, Takeya M, Komohara Y. Onionin A inhibits ovarian cancer progression by suppressing cancer cell proliferation and the protumour function of macrophages. Sci Rep. 2016 07 12; 6:29588.
    View in: PubMed
    Score: 0.069
  19. Ma C, Komohara Y, Ohnishi K, Shimoji T, Kuwahara N, Sakumura Y, Matsuishi K, Fujiwara Y, Motoshima T, Takahashi W, Yamada S, Kitada S, Fujimoto N, Nakayama T, Eto M, Takeya M. Infiltration of tumor-associated macrophages is involved in CD44 expression in clear cell renal cell carcinoma. Cancer Sci. 2016 May; 107(5):700-7.
    View in: PubMed
    Score: 0.068
  20. Ishiuchi K, Jiang WP, Fujiwara Y, Wu JB, Kitanaka S. Serralongamines B-D, three new Lycopodium alkaloids from Lycopodium serratum var. longipetiolatum, and their inhibitory effects on foam cell formation in macrophages. Bioorg Med Chem Lett. 2016 06 01; 26(11):2636-40.
    View in: PubMed
    Score: 0.068
  21. Saito Y, Ohnishi K, Miyashita A, Nakahara S, Fujiwara Y, Horlad H, Motoshima T, Fukushima S, Jinnin M, Ihn H, Takeya M, Komohara Y. Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma. Cancer Immunol Res. 2015 Dec; 3(12):1356-63.
    View in: PubMed
    Score: 0.065
  22. Khan S, Rahman HN, Okamoto T, Matsunaga T, Fujiwara Y, Sawa T, Yoshitake J, Ono K, Ahmed KA, Rahaman MM, Oyama K, Takeya M, Ida T, Kawamura Y, Fujii S, Akaike T. Promotion of atherosclerosis by Helicobacter cinaedi infection that involves macrophage-driven proinflammatory responses. Sci Rep. 2014 Apr 15; 4:4680.
    View in: PubMed
    Score: 0.059
  23. Ohnishi K, Komohara Y, Fujiwara Y, Takemura K, Lei X, Nakagawa T, Sakashita N, Takeya M. Suppression of TLR4-mediated inflammatory response by macrophage class A scavenger receptor (CD204). Biochem Biophys Res Commun. 2011 Aug 05; 411(3):516-22.
    View in: PubMed
    Score: 0.049
  24. Komohara Y, Hasita H, Ohnishi K, Fujiwara Y, Suzu S, Eto M, Takeya M. Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma. Cancer Sci. 2011 Jul; 102(7):1424-31.
    View in: PubMed
    Score: 0.048
  25. Anami T, Pan C, Fujiwara Y, Komohara Y, Yano H, Saito Y, Sugimoto M, Wakita D, Motoshima T, Murakami Y, Yatsuda J, Takahashi N, Suzu S, Asano K, Tamada K, Kamba T. Dysfunction of sinus macrophages in tumor-bearing host induces resistance to immunotherapy. Cancer Sci. 2024 Jan; 115(1):59-69.
    View in: PubMed
    Score: 0.029
  26. Mito R, Iriki T, Fujiwara Y, Pan C, Ikeda T, Nohara T, Suzuki M, Sakagami T, Komohara Y. Onionin A inhibits small-cell lung cancer proliferation through suppressing STAT3 activation induced by macrophages-derived IL-6 and cell-cell interaction with tumor-associated macrophage. Hum Cell. 2023 May; 36(3):1068-1080.
    View in: PubMed
    Score: 0.028
  27. Saito Y, Fujiwara Y, Miyamoto Y, Ohnishi K, Nakashima Y, Tabata Y, Baba H, Komohara Y. CD169+ sinus macrophages in regional lymph nodes do not predict mismatch-repair status of patients with colorectal cancer. Cancer Med. 2023 05; 12(9):10199-10211.
    View in: PubMed
    Score: 0.027
  28. Matsuzaki H, Komohara Y, Yano H, Fujiwara Y, Kai K, Yamada R, Yoshii D, Uekawa K, Shinojima N, Mikami Y, Mukasa A. Macrophage colony-stimulating factor potentially induces recruitment and maturation of macrophages in recurrent pituitary neuroendocrine tumors. Microbiol Immunol. 2023 Feb; 67(2):90-98.
    View in: PubMed
    Score: 0.027
  29. Saito Y, Fujiwara Y, Shinchi Y, Mito R, Miura Y, Yamaguchi T, Ikeda K, Urakami S, Nakashima Y, Sakagami T, Suzuki M, Tabata Y, Komohara Y. Classification of PD-L1 expression in various cancers and macrophages based on immunohistocytological analysis. Cancer Sci. 2022 Sep; 113(9):3255-3266.
    View in: PubMed
    Score: 0.026
  30. Shinchi Y, Ishizuka S, Komohara Y, Matsubara E, Mito R, Pan C, Yoshii D, Yonemitsu K, Fujiwara Y, Ikeda K, Tamada K, Sakagami T, Suzuki M. The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma. Cancer Immunol Immunother. 2022 Nov; 71(11):2645-2661.
    View in: PubMed
    Score: 0.026
  31. Pan C, Fujiwara Y, Horlad H, Iriki T, Shiraishi D, Komohara Y. Cyclic sulfur compounds targeting macrophage polarization into M2/protumor phenotype and their anti-tumor effects. Cancer Immunol Immunother. 2022 Jun; 71(6):1331-1343.
    View in: PubMed
    Score: 0.025
  32. Kosaka A, Ishibashi K, Nagato T, Kitamura H, Fujiwara Y, Yasuda S, Nagata M, Harabuchi S, Hayashi R, Yajima Y, Ohara K, Kumai T, Aoki N, Komohara Y, Oikawa K, Harabuchi Y, Kitada M, Kobayashi H, Ohkuri T. CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes. J Exp Med. 2021 11 01; 218(11).
    View in: PubMed
    Score: 0.025
  33. Fujimura R, Watanabe H, Nishida K, Fujiwara Y, Koga T, Bi J, Imafuku T, Kobayashi K, Komori H, Miyahisa M, Maeda H, Tanaka M, Matsushita K, Wada T, Fukagawa M, Maruyama T. a1-Acid Glycoprotein Attenuates Adriamycin-Induced Nephropathy via CD163 Expressing Macrophage Induction. Kidney360. 2020 05 28; 1(5):343-353.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)